LIGAND PHARMACEUTICALS INCORPORATED (LGND) Operating Margin
- Operating margin · 12 months: Value 32.61%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 32.61% | Operating income / revenue. Period ending 2026-06-30. $94.73M ÷ $290.54M × 100 ≈ 32.61% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 94.73M USD | Operating Income (Loss) |
| Revenue | 290.54M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 41.35M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94.73M | $290.54M | (m) | $41.35M | (m) | 32.61% |
| 2026-03-31 | $94.59M | $274.48M | (m) | $33.24M | (m) | 34.46% |
| 2025-12-31 | $41.00M | $268.09M | (m) | $81.18M | (m) | 15.29% |
| 2025-09-30 | $17.52M | $251.23M | (m) | $82.10M | (m) | 6.97% |
| 2025-06-30 | $-34.27M | $187.58M | (m) | $66.75M | (m) | -18.27% |
| 2025-03-31 | $-61.81M | $181.49M | (m) | $65.54M | (m) | -34.06% |
| 2024-12-31 | $-22.61M | $167.13M | (m) | $21.43M | (m) | -13.53% |
| 2024-09-30 | $-16.33M | $152.42M | (m) | $22.49M | (m) | -10.71% |
| 2024-06-30 | $-16.39M | $133.48M | (m) | $22.34M | (m) | -12.28% |
| 2024-03-31 | $725.00K | $118.31M | (m) | $23.84M | (m) | 0.61% |
| 2023-12-31 | $11.94M | $131.31M | (m) | $24.54M | (m) | 9.09% |
| 2023-09-30 | $-4.80M | $153.59M | (m) | $28.25M | (m) | -3.12% |
| 2023-06-30 | $4.46M | $179.95M | (m) | $31.95M | (m) | 2.48% |
| 2023-03-31 | $15.11M | $203.71M | (m) | $33.57M | (m) | 7.42% |
| 2022-12-31 | $3.04M | $196.25M | (m) | $36.08M | (m) | 1.55% |
| 2022-09-30 | $3.60M | $241.67M | (m) | $79.70M | (m) | 1.49% |
| 2022-06-30 | $18.67M | $240.42M | (m) | $74.61M | (m) | 7.76% |
| 2022-03-31 | $64.87M | $267.68M | (m) | $71.44M | (m) | 24.24% |
| 2021-12-31 | $78.89M | $277.13M | (m) | $69.01M | (m) | 28.47% |
| 2021-09-30 | $77.37M | (m) | (m) | $72.69M | (m) | (m) |
| 2021-06-30 | $65.41M | (m) | (m) | $68.60M | (m) | (m) |
| 2021-03-31 | $26.77M | (m) | (m) | $65.38M | (m) | (m) |
| 2020-12-31 | $25.84M | $186.42M | (m) | $59.39M | (m) | 13.86% |
| 2020-09-30 | $4.46M | (m) | (m) | $56.14M | (m) | (m) |
| 2020-06-30 | $-4.45M | (m) | (m) | $57.03M | (m) | (m) |
| 2020-03-31 | $-15.68M | (m) | (m) | $56.51M | (m) | (m) |
| 2019-12-31 | $807.08M | $120.28M | (m) | $55.91M | (m) | 670.99% |
| 2019-09-30 | $850.40M | (m) | $12.37M | $46.08M | (m) | (m) |
| 2019-06-30 | $878.92M | (m) | $10.68M | $37.83M | (m) | (m) |
| 2019-03-31 | $953.23M | (m) | $9.41M | $31.75M | (m) | (m) |
| 2018-12-31 | $163.73M | $251.45M | $6.34M | $27.86M | (m) | 65.11% |
| 2018-09-30 | $158.93M | (m) | (m) | $27.66M | (m) | (m) |
| 2018-06-30 | $152.06M | (m) | (m) | $26.93M | (m) | (m) |
| 2018-03-31 | $94.90M | $167.99M | (m) | $25.62M | (m) | 56.49% |
| 2017-12-31 | $68.08M | $141.10M | (m) | $26.89M | (m) | 48.25% |
| 2017-09-30 | $59.08M | $128.82M | (m) | $24.66M | (m) | 45.86% |
| 2017-06-30 | $48.05M | $117.07M | (m) | $25.80M | (m) | 41.05% |
| 2017-03-31 | $39.01M | $108.59M | (m) | $25.89M | (m) | 35.92% |
| 2016-12-31 | $43.88M | $108.97M | (m) | $21.22M | (m) | 40.27% |
| 2016-09-30 | $35.55M | $91.98M | (m) | $19.46M | (m) | 38.65% |
| 2016-06-30 | $39.09M | $88.06M | (m) | $15.10M | (m) | 44.38% |
| 2016-03-31 | $39.08M | $86.96M | (m) | $14.02M | (m) | 44.94% |
| 2015-12-31 | $27.33M | $71.91M | (m) | $13.38M | (m) | 38.00% |
| 2015-09-30 | $25.95M | $73.72M | (m) | $13.79M | (m) | 35.20% |
| 2015-06-30 | $20.88M | $70.99M | (m) | $14.27M | (m) | 29.42% |
| 2015-03-31 | $17.88M | $63.18M | (m) | $12.95M | (m) | 28.29% |
| 2014-12-31 | $19.63M | $64.54M | (m) | $12.12M | (m) | 30.41% |
| 2014-09-30 | $16.41M | $56.27M | (m) | $11.22M | (m) | 29.17% |
| 2014-06-30 | $15.95M | $54.31M | (m) | $10.61M | (m) | 29.38% |
| 2014-03-31 | $16.11M | $53.28M | (m) | $9.94M | (m) | 30.24% |
| 2013-12-31 | $14.94M | $48.97M | (m) | $9.27M | (m) | 30.51% |
| 2013-09-30 | $13.17M | $47.87M | (m) | $9.38M | (m) | 27.52% |
| 2013-06-30 | $8.68M | $41.24M | (m) | $9.61M | (m) | 21.03% |
| 2013-03-31 | $5.34M | $37.40M | (m) | $10.44M | (m) | 14.29% |
| 2012-12-31 | $574.00K | $31.39M | (m) | $10.79M | (m) | 1.83% |
| 2012-09-30 | $1.02M | $30.69M | (m) | $10.91M | (m) | 3.34% |
| 2012-06-30 | $-901.00K | $30.06M | (m) | $10.74M | (m) | -3.00% |
| 2012-03-31 | $20.00K | $31.78M | (m) | $11.12M | (m) | 0.06% |
| 2011-12-31 | $-698.00K | $30.04M | (m) | $10.29M | (m) | -2.32% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-29.30M | $23.54M | (m) | $22.07M | (m) | -124.50% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-9.97M | $38.94M | (m) | $39.87M | (m) | -25.60% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.